chlorpromazine has been researched along with octopamine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Harmar, AJ; Horn, AS | 1 |
| Pletscher, A | 1 |
| Roeder, T | 1 |
| Bockaert, J; Lafon-Cazal, M | 1 |
| Haefely, W | 1 |
| Johnson, DG; Kopin, IJ; Thoa, NB | 1 |
| Ohta, H; Ozoe, Y; Utsumi, T | 1 |
| Gut, LJ; Miller, JR; Ressa, NE; Stelinski, LL | 1 |
| Hadden, MK; Huang, Y; Jiang, K; Sun, J; Wang, Y; Woodruff, TK; Xiao, S; Zhang, J | 1 |
1 review(s) available for chlorpromazine and octopamine
| Article | Year |
|---|---|
[Drugs with effect on the adrenergic nerve fiber].
Topics: Aminocaproates; Amitriptyline; Amphetamine; Bretylium Compounds; Chlorpromazine; Disulfiram; Dopamine; Ephedrine; Guanethidine; Humans; Imipramine; Mental Disorders; Metaraminol; Methyldopa; Methyltyrosines; Monoamine Oxidase Inhibitors; Neurons; Norepinephrine; Octopamine; Prenylamine; Reserpine; Sympathetic Nervous System; Sympathomimetics; Tetrabenazine; Tyramine; Vascular Diseases | 1968 |
8 other study(ies) available for chlorpromazine and octopamine
| Article | Year |
|---|---|
Octopamine in mammalian brain: rapid post mortem increase and effects of drugs.
Topics: Animals; Brain; Chlordiazepoxide; Chlorpromazine; Fenclonine; Hydrazines; Imipramine; Iprindole; Kinetics; Male; Mice; Octopamine; Pargyline; Phenethylamines; Phenylalanine; Phenylethanolamine N-Methyltransferase; Postmortem Changes; Reserpine; Time Factors; Tyrosine | 1976 |
Transport of monoamines in membranes of adrenal chromaffin granules: physiological and pharmacological aspects.
Topics: Adrenal Medulla; Amines; Animals; Cattle; Cell Membrane Permeability; Chlorpromazine; Dopamine; Octopamine; Receptors, Neurotransmitter; Serotonin | 1976 |
A new octopamine receptor class in locust nervous tissue, the octopamine 3 (OA3) receptor.
Topics: Adrenergic Agonists; Adrenergic Antagonists; Animals; Binding Sites; Chlorpromazine; Female; Grasshoppers; Male; Metoclopramide; Mianserin; Neurons; Octopamine; Phentolamine; Receptors, Adrenergic; Receptors, Biogenic Amine; Regression Analysis | 1992 |
Pharmacological characterization of octopamine-sensitive adenylate cyclase in the flight muscle of Locusta migratoria L.
Topics: Adenylyl Cyclases; Adrenergic alpha-Agonists; Animals; Catecholamines; Chlorphenamidine; Chlorpromazine; Flight, Animal; Grasshoppers; In Vitro Techniques; Male; Metoclopramide; Mianserin; Muscles; Octopamine; Phentolamine; Prazosin; Receptors, Adrenergic; Receptors, Biogenic Amine; Serotonin; Synephrine; Tyramine | 1985 |
Inhibition of norepinephrine biosynthesis by chlorpromazine in the guinea-pig vas deferens.
Topics: Animals; Carbon Isotopes; Chlorpromazine; Cocaine; Depression, Chemical; Dihydroxyphenylalanine; Dopamine; Electric Stimulation; Guinea Pigs; Hypogastric Plexus; In Vitro Techniques; Male; Mixed Function Oxygenases; Monoamine Oxidase; Norepinephrine; Octopamine; Tritium; Tyrosine; Vas Deferens | 1971 |
B96Bom encodes a Bombyx mori tyramine receptor negatively coupled to adenylate cyclase.
Topics: Adenylyl Cyclases; Animals; Bombyx; Cells, Cultured; Chlorpromazine; Cloning, Molecular; Colforsin; Cyclic AMP; Dopamine; Drug Interactions; Humans; Neurotransmitter Agents; Norepinephrine; Octopamine; Receptors, Biogenic Amine; Tyramine; Yohimbine | 2003 |
Increased EAG responses of tortricid moths after prolonged exposure to plant volatiles: evidence for octopamine-mediated sensitization.
Topics: Adrenergic alpha-Agonists; Animals; Chlorpromazine; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Male; Moths; Octopamine; Plant Extracts; Plants; Sex Attractants; Volatilization | 2003 |
A platform utilizing
Topics: Animals; Biological Assay; Chlorpromazine; Contraceptive Agents; Dexmedetomidine; Drosophila melanogaster; Drug Approval; Female; Hormones; Mice; Octopamine; Ovarian Follicle; Ovulation; United States; United States Food and Drug Administration | 2021 |